Opus Genetics is trading up 5.06% at $3.63 on October 28, 2026, with biotech-sector strength potentially contributing. - No clear company-specific announcement explaining the move surfaced in the search. - The company’s latest listed press release was its October 21 FDA clearance announcement, not a new development today. - Supplied sector context shows XBI up 2.18%, while major indexes are up less than 0.5%.